Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₩1,719,006.69, with a 24-hour trading volume of ₩13.16B. The asset's market cap is ₩1.53P, after moving 0.17% in the last day.
Tokenized Eli Lilly And Co is trading at ₩1,722,776.56, with a tokenized market cap of ₩66.22B and a 24-hour trading volume of ₩3.9B. The tokenized asset has moved -0.42% in the past 24 hours.